about
High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomasZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumRegulation of p53 tetramerization and nuclear export by ARCCharacterisation of HER heterodimers in breast cancer using in situ proximity ligation assayDifferential oestrogen receptor binding is associated with clinical outcome in breast cancerBCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedThe NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor geneMicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeThe emerging role of the LIV-1 subfamily of zinc transporters in breast cancerPathological validation and significance of micrometastasis in sentinel nodes in primary breast cancerThe diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classificationEvidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical managementThe number of women who would need to be screened regularly by mammography to prevent one death from breast cancerELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsPhyllodes tumours of the breast: a consensus reviewThe prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtypeSmall molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.Phyllodes tumours of the breast: a clinicopathological review of thirty-two casesThe somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesPathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-upThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsA prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin undePathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers.Detection and quantification of microRNAs in laser-microdissected formalin-fixed paraffin-embedded breast cancer tissues.A gene-expression signature to predict survival in breast cancer across independent data sets.Three dimensional reconstruction of a human breast carcinoma using routine laboratory equipment and immunohistochemistry.Fluorescent location of tumour cells in fine needle aspirates.Assessing agreement between multiple raters with missing rating information, applied to breast cancer tumour grading.High-resolution array CGH clarifies events occurring on 8p in carcinogenesisThe expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients.Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesChemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinomaHAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerInvestigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification.Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Projectβ-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.Bilateral breast carcinomas: do they have similar mammographic features?
P50
Q21195240-0B0DDB59-CDDC-4CC5-BB40-B7ED711A4B47Q24293658-52FD9474-F213-4C49-A31D-5C52EDA9B7A9Q24304068-739A0A49-9254-4913-B8DA-EBBBB80A33E2Q24337937-1F355955-8697-4AEA-AC57-673711A54A72Q24595511-AF030203-870E-4023-8A9E-309E302E21B3Q24610409-30F0F7B4-88CB-4D62-8B96-616F3BC3C8BFQ24645371-D46B106A-AB68-4408-99DF-20A6C4FE975FQ24646090-5D957903-5F01-4584-895B-DA7FC05958EAQ24682854-45867C41-AD91-4063-95FE-2A2FDE551075Q24793510-82942490-02D0-4776-9A53-790B991A8A1CQ24803360-301E8C9F-E47F-4FAB-9C14-A2E5F2A2D612Q24815660-CB97509E-6051-49D6-9FC1-974CFCAC1A44Q26782664-12E00C2F-F3C2-4CC4-B292-6F354A894CD0Q26852347-0950F9CF-AA84-43F4-B022-1CC607554278Q27345430-B41752E1-875C-498B-BC13-FBADEAF703E1Q28079009-B691E01E-E67A-442A-AEA3-FE254E6063C2Q28247404-D84F2A19-C743-4C72-84FD-1B176ACD47F8Q28261026-7068F44A-1A37-4AAE-8521-5BF221D92B91Q28270537-E385AFEF-440E-435B-9DFA-0E3D38697F26Q28275430-96F25FDB-4461-42CB-AE19-69C759A87BDEQ28306437-366465F5-4A70-4A71-8BA7-ED0A028CA437Q29614700-BFB95C4D-2643-4A2C-98EA-29EB40962031Q30788689-C76A2277-A748-4D8D-B6B1-94C45AE8DD4BQ30814926-D5249888-FDDC-49B8-8A22-3004DA3EBFA7Q30830304-DB071B01-34A6-4C7E-884E-7F515E788E9AQ31023444-4C337980-36C5-4995-BD2B-60187CAE5A01Q31057290-8E455836-ABE9-4024-970B-07637C3F205EQ33222426-4C0C8692-3BF4-45C0-9864-F6F398DED529Q33293279-C7CED49A-B30F-485C-B30F-CF56873AF3EFQ33359537-E02F8DA9-832C-43DE-B3F7-9B9A6BECA41FQ33374399-7324B0A3-6D00-4C46-A7E6-ABD84FACB4B1Q33421063-1B509679-3AEA-4840-A39A-05FB72858E9FQ33526915-4E803BA8-BE82-4314-94BB-611464A603EDQ33593016-5A216E40-67E8-4F7C-B2C9-DF2E1F686F75Q33593895-60F1E99F-BDFC-4F1D-84B5-A0EF5DB100E3Q33613602-5DA1C32E-D288-48E1-B279-6BFE32E48210Q33627215-2A0E08D2-7B32-4259-9334-F8D79FE6BFF4Q33630888-54A5FACE-BE0D-4A8C-B315-86537D1C795AQ33652448-E20BA400-C2CF-4150-8D3B-214894147077Q33705710-93470BCE-1333-4651-B719-4CFF8160771A
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ian O. Ellis
@ast
Ian O. Ellis
@en
Ian O. Ellis
@es
Ian O. Ellis
@nl
Ian O. Ellis
@sl
type
label
Ian O. Ellis
@ast
Ian O. Ellis
@en
Ian O. Ellis
@es
Ian O. Ellis
@nl
Ian O. Ellis
@sl
altLabel
Ian Ellis
@en
prefLabel
Ian O. Ellis
@ast
Ian O. Ellis
@en
Ian O. Ellis
@es
Ian O. Ellis
@nl
Ian O. Ellis
@sl
P1006
P214
P1006
P106
P1153
36039440700
57203666573
P21
P214
P2456
P31
P496
0000-0001-5292-8474
P734
P7859
lccn-n85279197